Human-derived alternatives to fetal bovine serum in cell culture

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 6, 2013, Pages 417-423

  Witzeneder, Karin ^a,b   Lindenmair, Andrea ^b,c   Gabriel, Christian ^a,b   Höller, Katharina ^a,b   Theiß, Denise ^a,b   Redl, Heinz ^b,c   Hennerbichler, Simone ^a,b  

^a Red Cross Blood Transfusion Service of Upper Austria Austrian Cluster for Tissue Regeneration   (Austria)

^b Austrian Cluster for Tissue Regeneration ^*  (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

Fetal bovine serum; Human adipose tissue derived stem cells; Human platelet lysate; Human serum; Regenerative medicine

Indexed keywords

GROWTH FACTOR; PROTEIN;

ADIPOSE DERIVED STEM CELL; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FETAL BOVINE SERUM; FIBROBLAST; HUMAN; HUMAN CELL; MICROSCOPY; PH; QUALITY CONTROL; SERUM; CELL LYSATE; CELLULAR PARAMETERS; CONCENTRATION (PARAMETERS); ERYTHROCYTE COUNT; FEASIBILITY STUDY; FETUS; HUMAN CELL CULTURE; HUMAN PLATELET LYSATE; LEUKOCYTE COUNT; NONHUMAN; POPULATION DOUBLING TIME; SKIN FIBROBLAST; STEM CELL EXPANSION; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 84896518982     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000356236     Document Type: Article

References (26)

1. www.clinicaltrials.gov/ct2/results?term=cell+therapy.
2. Martin MJ, Muotri A, Gage F, Varki A: Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005;11:228-232.
3. Tekkatte C, Gunasingh GP, Cherian KM, Sankaranarayanan K: 'Humanized' stem cell culture techniques: the animal serum controversy. Stem Cells Int 2011;2011:504723.
4. Note for Guidance on minimizing the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3). Official Journal of the European Union 2011/C 73/01 www.emea.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/ WC500003675.pdf.
5. Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, Strunk D, Klüter H: Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009;27:2331-2341.
6. Pratama G, Vaghjiani V, Tee JY, Liu YH, Chan J, Tan C, Murthi P, Gargett C, Manuelpillai U: Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One 2011;6:e26136.
7. Liu Y, Kalén A, Risto O, Wahlström O: Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Rep Reg 2002;10:336-340.
8. Rauch C, Feifel E, Amann EM, Spötl HP, Schennach H, Pfaller W, Gstraunthaler G: Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. ALTEX 2011;28:305-316.
9. Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, Schettert IT, Krieger JE: Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 2009; 49:2680-2685.
10. Chieregato K, Castegnaro S, Madeo D, Astori G, Pegoraro M, Rodeghiero F: Epidermal growth factor, basic fibroblast growth factor and plateletderived growth factor-bb can substitute for fetal bovine serum and compete with human plateletrich plasma in the ex-vivo expansion of mesenchymal stromal cells derived from adipose tissue. Cyto therapy 2011;13:933-943.
11. Burnouf T, Tseng YH, Kuo YP, Su CY: Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Transfusion 2008;48:1090-1098.
12. Hildner F, Eder MJ, Hofer K, Aberl J, Redl H, van Griensven M, Gabriel C, Peterbauer-Scherb A: Human platelet lysate successfully promotes proliferation and subsequent chondrogenic differentiation of adipose-derived stem cells: a comparison with articular chondrocytes. J Tissue Eng Regen Med 2013; doi: 10.1002/term.1649.
13. Wolbank S, Peterbauer A, Wassermann E, Hennerbichler S, Voglauer R, van Griensven M, Duba HC, Gabriel C, Redl: Labelling of human adiposederived stem cells for non-invasive in vivo cell tracking. Cell Tissue Bank 2007;8:163-177.
14. Pittenger MF, AM Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
15. de Girolamo L, Sartori MF, Albisetti W, Brini AT: Osteogenic differentiation of human adipose-derived stem cells: comparison of two different inductive media. J Tissue Eng Regen Med 2007;1:154-157.
16. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, Redl H, Gabriel C: Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007;13:1173-1183.
17. Wolbank S, Stadler G, Peterbauer A, Gillich A, Karbiener M, Streubel B, Wieser M, Katinger H, van Griensven M, Redl H, Gabriel C, Grillari J, Grillari-Voglauer R: Telomerase immortalized human amnion-and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. Tissue Eng Part A 2009;15:1843-1854.
18. Plöderl K, Strasser C, Hennerbichler S, Peterbauer-Scherb A, Gabriel C: Development and validation of a production process of platelet lysate for autologous use. Platelets 2011;22:204-209.
19. Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Corrêa do Amaral RJ, Granjeiro JM, Borojevic R: Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013;4:67.
20. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D: Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 2008;14:185-196.
21. Lohmann M, Walenda G, Hemeda H, Joussen S, Drescher W, Jockenhoevel S, Hutschenreuter G, Zenke M, Wagner W: Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS ONE 2012;7:e37839.
22. Zaragosi LE, Ailhaud G, Dani C: Autocrine fibroblast growth factor 2 signaling is critical for selfrenewal of human multipotent adipose-derived stem cells. Stem Cells 2006;24:2412-2419.
23. Kemptner J, Witzeneder K, Hennerbichler S, Gabriel C: Proteomic analysis of human derived cell culture supplements. Transfus Med Hemother 2013;40(6):413-415.
24. Josh F, Kobe K, Tobita M, Tanaka R, Suzuki K, Ono K, Hyakusoku H, Mizuno H: Accelerated and safe proliferation of human adipose-derived stem cells in medium supplemented with human serum. J Nippon Med Sch 2012;79:444-452.
25. Kocaoemer A, Kern S, Kluter H, Bieback K: Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007;25:1270-1278.
26. Lai WT, Krishnappa V, Phinney DG: Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels. Stem Cells 2011;29:1102-1111.